Product Information
AMLODIPINE-OLMESARTAN 5-40 MG is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.2934 per EA under NDC 31722044690. Its NADAC has been published 25 times since Jan 7, 2026.
Strength
5; 40 mg/1; mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722044690
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA209591On Market Since
2/14/2025
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-OLMESARTAN 5-40 MG has been published 25 times since Jan 7, 2026, and over the history we have for it it has declined 5.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2934 per EA |
|---|---|
| All-time high | $0.3118 (Jan 14, 2026) |
| All-time low | $0.2762 (Apr 22, 2026) |
| 52-week high | $0.3118 |
| 52-week low | $0.2762 |
| Median price | $0.2841 |
| Average price | $0.2878 |
| Largest weekly change | -5.4% (Feb 18, 2026) |
| Weeks tracked | 25 |
| Tracking since | Jan 7, 2026 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of AMLODIPINE-OLMESARTAN 5-40 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 5-40 MG, manufactured by Camber Pharmaceuticals Inc., is $0.2934 per EA (NDC 31722044690), effective Jun 24, 2026.
How has the price of AMLODIPINE-OLMESARTAN 5-40 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 5-40 MG has declined 5.9%. It has been tracked across 25 weekly CMS publications since Jan 7, 2026.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 5-40 MG?
Since Jan 7, 2026, the NADAC for AMLODIPINE-OLMESARTAN 5-40 MG has ranged from a low of $0.2762 (Apr 22, 2026) to a high of $0.3118 (Jan 14, 2026), with a median of $0.2841 per EA.
Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 5-40 MG?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as AMLODIPINE-OLMESARTAN 5-40 MG, but none are currently priced below it.
Who manufactures AMLODIPINE-OLMESARTAN 5-40 MG?
AMLODIPINE-OLMESARTAN 5-40 MG (NDC 31722044690) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification